HomeRADICO › Filing
🔔 Get instant alerts when RADICO files quarterly results on BSE Start free trial →

Investor Presentation for Q1 FY2027.

Filed: 28 Jul 2026, 14:24 IST Exchange: BSE Category: Financial Results — Investor Presentation
AI summary - Q1 FY2027 revenue 1683.7 Cr +11.8% y-y; EBITDA 348.1 Cr +50.9%, margin 20.7% +536 bps y-y - Prestige & Above volume grew 35.8% y-y, total IMFL volume +2.8% - Net debt reduced by 138 Cr since March 2026; net debt free expected by Q2 FY2027 - Management expects Prestige & Above volume growth over 25% for FY2027 - EBITDA margin guidance around 20% for full year FY2027 - Premiumisation and innovation driving strong growth in vodka and whisky segments - Marketing spend maintained at 6-8% of IMFL revenues to support growth - Chairman highlights structural tailwinds and investments in brand, capacity, and supply chain - Managing Director confident in long-term growth and margin expansion
Source: Original filing PDF — view on exchange portal
⚡ You're reading this after the fact — subscribers got it instantly
ISA
Indian Stock Alerts BOT
🚨 RADICO — Quarterly Results
Revenue: ₹2,35,800 Cr (+12% YoY)
PAT: ₹19,200 Cr (+17% YoY)
EBITDA margin: 16.8%
Board declared ₹10/share dividend. Jio adds 8M subs.
✓✓ 6:47 PM
🎧
Instant audio summaries2-min AI concall recap delivered with every earnings alert
📊
20-quarter financialsRevenue, PAT, EBITDA, margins — auto-extracted from filings
🔍
Forensic red-flag screenAudit, governance, accruals & RPT flags scored automatically
Instant Telegram alertsResults, board meetings, insider trades — within minutes

Add RADICO to your watchlist — all of this, automated.

Sign in with Google
14-day Pro trial · No credit card · Cancel anytime

More on Radico Khaitan Limited

Important. The summary above is generated automatically from Radico Khaitan Limited's own public regulatory filing under SEBI LODR. Indian Stock Alerts is not a SEBI-registered Research Analyst or Investment Adviser. This page is informational, not investment advice, a recommendation to buy or sell any security, or any opinion about the company's business, governance or financial health. Always read the original filing before acting and consult a registered adviser for investment decisions.